Good news, eaters and readers — over the past five weeks, 20 new restaurants have opened in our area, so there's no reason to ...

CLEVELAND, Ohio (WOIO) - The Cavaliers celebrated Nick Gilbert and his legacy by hosting their third annual Bow Tie Night. The special game kicked off with the opening of Gilly’s, a new sports bar ...

The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults and children. The drug, developed by SpringWorks Therapeutics ...

Sumrall, MD The FDA has approved an oral, small molecule MEK inhibitor for adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 who have symptomatic plexiform ...

"Nobody ever knew what happened to them. They just disappeared." Jamie Smallboy is the founder of the Red Ribbon Skirt Project. (Submitted by Jamie Smallboy ) Smallboy says feeling the spirit of ...

Sign up and we'll send you a daily e-mail with the latest news, opinion, food, arts and culture coverage.

What is neurofibromatosis type 1 (NF1)? Neurofibromatosis type 1 (NF1) is a genetic condition where tumors (mostly benign) grow on skin, nerves, and bones. It is also known as von Recklinghausen ...

Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult and pediatric patients. The FDA has approved SpringWorks Therapeutics’ ...

Gomekli is the first medication approved for both adult and pediatric patients with NF1-PN. The Food and Drug Administration (FDA) has approved Gomekli ™ (mirdametinib) for the treatment of ...